Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptid
SPG20
Wirt: Synthetic
BP, Imm
Produktnummer ABIN2816480
Kurzübersicht für Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptid (ABIN2816480)
Target
SPG20
(Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunogen (Imm)
-
-
Sequenz
- EASGTDVKQL DQGNK
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
-
Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at ambient temperature, store at -20°C.
-
-
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
Target
-
Sie sind hier:
